Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and internal validation of a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas.

Frontiers in endocrinology - 1 Jan 2023

Zhou Yue, Gao Yinjie, Ma Xiaosen, Li Tianyi, Cui Yunying, Wang Yu, Li Ming, Zhang Dingding, Tong Anli

Abstract excerpt

Aim: To develop and internally validate a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas (PPGLs). Methods: Clinical data of patients with PPGLs who presented to Peking Union Medical College Hospital from 2013 to 2022 and underwent genetic testing were retrospectively collected. Variables were screened by backward stepwise and clinical significance and were used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Iodine Radioisotopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Paraganglioma

Share to Pheochromocytoma

Share to Succinate Dehydrogenase

Source

Open in PubMed Open full text

Identifiers

PMID: 38179299
DOI: 10.3389/fendo.2023.1285631
PMCID: PMC10764617

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and internal validation of a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas.PMID 38179299Read ↗

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task ForceSemantic proximity Read ↗

[Clinical and genetic characteristics and genotype-phenotype correlations of pheochromocytoma and paraganglioma in children and adolescents].Semantic proximity Read ↗

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSemantic proximity Read ↗

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity Read ↗

SDHC phaeochromocytoma and paraganglioma: A UK‐wide case seriesSemantic proximity Read ↗

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Metastatic pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity Read ↗

Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted TherapiesSemantic proximity Read ↗

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patientsSemantic proximity Read ↗

[Risk predication for metastasis and grading system in complex adrenal pheochromocytoma and paraganglioma].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.